Clinical Trials Directory

Trials / Completed

CompletedNCT03971981

Xylitol Chewing-gums: Concentration in Saliva and Antibacterial Effect

Xylitol Chewing-gums: Concentration in Saliva and Antibacterial Effect (In-vivo and In-vitro Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Università degli Studi di Sassari · Academic / Other
Sex
All
Age
19 Years – 26 Years
Healthy volunteers
Accepted

Summary

a double-blind cross-over in vivo study was performed to measure the salivary concentration of Xylitol released from the two chewing gums containing different amount of the polyol. The study had a cross-over design: the first half of the sample used the chewing-gum with Xylitol as the only sweeteners (64.5% of chewing-gum weight) and the other half use the chewing-gum with Xylitol among the sweeteners (22% of chewing-gum weight), after a 7-days wash-out period, the two sub-groups inverted the chewing gums. Subjects were instructed to consume the products as they normally would be consumed.

Detailed description

x

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT100% Xylitol GumSubjects were instructed to consume the gums as they normally would be consumed.
DIETARY_SUPPLEMENT22% Xylitol GumSubjects were instructed to consume the gums as they normally would be consumed.

Timeline

Start date
2018-02-01
Primary completion
2018-05-31
Completion
2019-05-28
First posted
2019-06-03
Last updated
2019-06-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03971981. Inclusion in this directory is not an endorsement.